Results 171 to 180 of about 34,461 (204)
Untargeted metabolomics for triaging of cytochrome b inhibitors during Chagas' disease drug discovery. [PDF]
PLoS Negl Trop DisMacLeod AK +5 more
europepmc +1 more source
High Spatial Resolution Ensemble Species Distribution Modeling of <i>Rhodnius prolixus</i>, Vector of Chagas Disease, in Western Venezuela. [PDF]
GeohealthGao Y, Añez N, Chaves LF.
europepmc +1 more source
Chagas Disease, an Endemic Disease in the United States. [PDF]
Emerg Infect DisBeatty NL +4 more
europepmc +1 more source
Validation of Guanidine-EDTA as a Preservative Agent for the Analysis of miRNAs and mRNAs in Blood Samples of Chagas Disease Patients. [PDF]
PathogensFaier-Pereira A +4 more
europepmc +1 more source
Towards effective coverage of Chagas disease: a community-based approach in migrant populations. [PDF]
Int J Equity HealthGómez I Prat J +13 more
europepmc +1 more source
External Quality Assessment as a strategy for Chagas disease surveillance: a study in four municipalities of Pernambuco. [PDF]
Rev Soc Bras Med TropSoares ENL +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of Internal Medicine, 2023
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is a leading neglected tropical disease in the United States. An estimated 240 000 to 350 000 persons in the United States are infected, primarily immigrants from Mexico, Central America, and South America, where the disease is endemic.
Natasha S. Hochberg, Susan P. Montgomery
openaire +2 more sources
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is a leading neglected tropical disease in the United States. An estimated 240 000 to 350 000 persons in the United States are infected, primarily immigrants from Mexico, Central America, and South America, where the disease is endemic.
Natasha S. Hochberg, Susan P. Montgomery
openaire +2 more sources